234 related articles for article (PubMed ID: 15180567)
1. In silico prediction models for blood-brain barrier permeation.
Ecker GF; Noe CR
Curr Med Chem; 2004 Jun; 11(12):1617-28. PubMed ID: 15180567
[TBL] [Abstract][Full Text] [Related]
2. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
3. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
Shityakov S; Neuhaus W; Dandekar T; Förster C
Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
[TBL] [Abstract][Full Text] [Related]
4. The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability.
Lingineni K; Belekar V; Tangadpalliwar SR; Garg P
Mol Divers; 2017 May; 21(2):355-365. PubMed ID: 28050687
[TBL] [Abstract][Full Text] [Related]
5. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
Vucicevic J; Nikolic K; Dobričić V; Agbaba D
Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
7. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.
Radan M; Djikic T; Obradovic D; Nikolic K
Eur J Pharm Sci; 2022 Jan; 168():106056. PubMed ID: 34740787
[TBL] [Abstract][Full Text] [Related]
8. Permeability changes in the blood-brain barrier: causes and consequences.
Pardridge WM; Connor JD; Crawford IL
CRC Crit Rev Toxicol; 1975 Jan; 3(2):159-99. PubMed ID: 1093805
[TBL] [Abstract][Full Text] [Related]
9. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery.
Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R
Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197
[TBL] [Abstract][Full Text] [Related]
10. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
[TBL] [Abstract][Full Text] [Related]
11. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
12. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.
Saxena D; Sharma A; Siddiqui MH; Kumar R
Curr Pharm Biotechnol; 2019; 20(14):1163-1171. PubMed ID: 31433750
[TBL] [Abstract][Full Text] [Related]
13. Transporter-mediated permeation of drugs across the blood-brain barrier.
Tamai I; Tsuji A
J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
[TBL] [Abstract][Full Text] [Related]
14. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.
Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR
Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578
[TBL] [Abstract][Full Text] [Related]
16. Drug transfer across the blood-brain barrier and improvement of brain delivery.
Jolliet-Riant P; Tillement JP
Fundam Clin Pharmacol; 1999; 13(1):16-26. PubMed ID: 10027084
[TBL] [Abstract][Full Text] [Related]
17. Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.
Passeleu-Le Bourdonnec C; Carrupt PA; Scherrmann JM; Martel S
Pharm Res; 2013 Nov; 30(11):2729-56. PubMed ID: 23801086
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.
Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B
Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731
[TBL] [Abstract][Full Text] [Related]
19. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
20. In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
Mensch J; Oyarzabal J; Mackie C; Augustijns P
J Pharm Sci; 2009 Dec; 98(12):4429-68. PubMed ID: 19408294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
